These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2280 related items for PubMed ID: 12051571

  • 21. Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients.
    Persiani S, D'Amato M, Makovec F, Arshad SH, Holgate ST, Rovati LC.
    Biopharm Drug Dispos; 2001 Mar; 22(2):73-81. PubMed ID: 11745909
    [Abstract] [Full Text] [Related]

  • 22. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog.
    Webber C, Stokes CA, Persiani S, Makovec F, McBurney A, Kapil RP, John BA, D'Amato M, Chasseaud LF.
    Eur J Drug Metab Pharmacokinet; 2004 Mar; 29(1):15-23. PubMed ID: 15151166
    [Abstract] [Full Text] [Related]

  • 23. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH, Hussey EK, Shaw S, Fuseau E, Duquesnoy C, Pakes GE.
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects.
    Krösser S, Tillner J, Fluck M, Ungethüm W, Wolna P, Kovar A.
    Int J Clin Pharmacol Ther; 2007 May; 45(5):271-80. PubMed ID: 17542349
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and pharmacodynamic characteristics of aranidipine sustained-release, enteric-coated tablets in healthy Chinese men: a phase I, randomized, open-label, single- and multiple-dose study.
    Jiang J, Tian L, Huang Y, Li Y, Xu L.
    Clin Ther; 2008 Jul; 30(7):1290-9. PubMed ID: 18691988
    [Abstract] [Full Text] [Related]

  • 26. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
    Chu NN, Huang K, Que LL, Ding Y, Gu XH, Zhang L, Wang JK, Chen XP, Sun ZG, He Q.
    Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285
    [Abstract] [Full Text] [Related]

  • 27. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
    Da Ros L, Squassante L, Milleri S.
    Clin Pharmacokinet; 2003 Jul; 42(1):99-106. PubMed ID: 12489980
    [Abstract] [Full Text] [Related]

  • 28. Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
    Roy P, Jakate AS, Patel A, Abramowitz W, Wangsa J, Persiani S, Kapil R.
    J Clin Pharmacol; 2005 Mar; 45(3):329-36. PubMed ID: 15703367
    [Abstract] [Full Text] [Related]

  • 29. Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers.
    Iovino M, Feifel U, Yong CL, Wolters JM, Wallenstein G.
    Cephalalgia; 2004 Aug; 24(8):645-56. PubMed ID: 15265053
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.
    Chu NN, Chen WL, Xu HR, Li XN.
    Clin Drug Investig; 2009 Aug; 29(7):451-457. PubMed ID: 19499962
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
    Heikkinen H, Saraheimo M, Antila S, Ottoila P, Pentikäinen PJ.
    Eur J Clin Pharmacol; 2001 Aug; 56(11):821-6. PubMed ID: 11294372
    [Abstract] [Full Text] [Related]

  • 32. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
    Stangier J, Rathgen K, Stähle H, Gansser D, Roth W.
    Br J Clin Pharmacol; 2007 Sep; 64(3):292-303. PubMed ID: 17506785
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [Abstract] [Full Text] [Related]

  • 34. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L, Gidal B, Blakey G, Tayo B, Morrison G.
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [Abstract] [Full Text] [Related]

  • 35. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat.
    Webber C, Stokes CA, Persiani S, Makovec F, McBurney A, Kapil RP, John BA, Houchen TL, D'Amato M, Chasseaud LF.
    Eur J Drug Metab Pharmacokinet; 2003 Nov; 28(3):201-12. PubMed ID: 14527093
    [Abstract] [Full Text] [Related]

  • 36. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA, Antibacterial Resistance Leadership Group.
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [Abstract] [Full Text] [Related]

  • 37. Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers.
    Martin DE, Blum R, Doto J, Galbraith H, Ballow C.
    Clin Pharmacokinet; 2007 Aug; 46(7):589-98. PubMed ID: 17596104
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
    Zhou H, Wu G, Hu X, Zhu M, Zhai Y, Liu J, Shentu J, Wu L.
    Clin Ther; 2015 Jun 01; 37(6):1292-300. PubMed ID: 25869627
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
    Wenzler E, Ellis-Grosse EJ, Rodvold KA.
    Antimicrob Agents Chemother; 2017 Sep 01; 61(9):. PubMed ID: 28630194
    [Abstract] [Full Text] [Related]

  • 40. Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.
    Tarral A, Dostert P, Guillevic Y, Fabbri L, Rondelli I, Mariotti F, Imbimbo BP.
    J Clin Pharmacol; 2003 Aug 01; 43(8):901-11. PubMed ID: 12953347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 114.